AstraZeneca, Samsung reach $331M biologics manufacturing deal amid Korean CMO's expansion push
Unlike some other manufacturers, Samsung Biologics has enjoyed a revenue boost from the novel coronavirus pandemic, and it's accelerating its expansion plans to match. | Unlike some other manufactu...
fiercepharma.com